About this trial
The purpose of this study will be to evaluate the effect of laser therapy on lateral pterygoid muscle in patients with Wilke's stage I and II temporomandibular disorders (TMD).
Eligibility criteria
Qualifiers
Patients age between 16-50 years with no sex predilection.
Patients who will be free from any systemic diseases that affect temporomandibular joint.
Patients who will be diagnosed with wilk's stage I and II temporomandibular disorders (TMD).
Patients who will be ready to give informed consent.
Disqualifiers
Patients with previous temporo-mandibular surgeries.
Patients with previous facial fracture.
Patients who will be under another type of treatment for TMD (e.g., occlusal splints, pharmacological drugs, or head and neck surgery).
Patients who will not attend the proposed treatment sessions or follow-up visits.
Trial design
Treatments tested in this trial
- laser therapy in TMD